2m 2m 2m 2m 2m 2m 2m
BioAtla (BCAB)
NASDAQ
$3.26+$0.08 (+2.61%)
Price as of Aug 21, 2026 7:30 PM EDT- $5.3MMarket Cap
- -82.14%1-Year Change
- BiotechnologyIndustry
BioAtla (BCAB)
$3.26+$0.08 (+2.61%)
BCAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.18 | ||
Change | $0.00 (0.00%) | ||
Open | $3.26 | ||
High | $3.41 | ||
Low | $3.03 | ||
Previous Close | $3.18 | ||
Volume | 88,744 | ||
30-Day Average Volume | 56,902 | ||
1-Week Change | 2.91% | ||
1-Month Change | -13.82% | ||
1-Year Change | -82.14% | ||
3-Year Change | -97.61% | ||
5-Year Change | -99.84% | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $9.5M | ||
Market Cap | $5.3M | ||
Enterprise Value | $3.8M | ||
Period: QTR TTM FY | |||
Revenue | $6.5M | ||
Net Income | $452,000.00 | ||
Free Cash Flow | -$419,000.00 | ||
EBIT | $452,000.00 | ||
EBITDA | $452,000.00 | ||
Net Working Capital | -$16.8M | ||
EPS | $0.27 | ||
Enterprise Value/EBITDA | 8 | ||
Enterprise Value/Revenue | 1 | ||
P/B | -0 | ||
P/E | 12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 04/06/2026 | ||
Earnings & Revenue